News | Radial Access | March 08, 2016

Merit Medical Announces First European ThinkRadial Education Course

Course is designed to provide training to interventionalists on the transradial approach

Merit Medical, ThinkRadial training course, radial interventional access, first in Europe

March 8, 2016 — Merit Medical Systems Inc. announced that the first ThinkRadial course to be held at its European headquarters in Maastricht, the Netherlands, took place Feb. 25-26. The ThinkRadial program serves to educate and train interventional cardiologists, interventional radiologists and vascular surgeons around the world about using the radial artery, as an alternative to the femoral artery, to gain access for interventional procedures.

The two-day ThinkRadial course, which began in the United States in 2014, provides a full spectrum of didactic and hands-on educational opportunities. This course marks the first in a series of two-day course offerings slated for 2016 at Merit’s European HQ, in addition to ThinkRadial courses in the U.S. and workshops and symposia throughout the year around the world.

The course will feature two concurrent tracks for interventional cardiologists and interventional radiologists, and will be held in Merit’s new training center that features hands-on training modules, including flow models for radial and femoral catheterization and pulsatile puncture arms. The Interventional Cardiology track will be proctored by Tom Kiernan, M.D., of Limerick Hospital, Limerick, Ireland; and the Interventional Radiology track will be led by Darren Klass, M.D., of Vancouver General Hospital & UBC Hospital in Vancouver, British Columbia, Canada. In addition to the course proctors, Ferdinand Kiemeneij, M.D., regarded as the “father of transradial intervention,” will speak as a special guest of honor about his experience with radial access and his vision for the future of the technique.

“I am honored to join the esteemed faculty at this European training event to discuss the benefits of transradial approach for interventional procedures,” said Kiemeneij. “Transradial intervention is rapidly gaining acceptance globally, and I believe that training and education are paramount to increasing adoption and bringing this option to patients worldwide. I look forward to participating in this course and educating attendees on the latest science and research about the radial approach and my experience in performing this procedure.”

For more information: www.meritmedical.com

Related Content

Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths
News | Cath Lab | April 09, 2019
A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce...
TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy
Technology | Cath Lab | April 08, 2019
TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its...
Overlay Init